Literature DB >> 8151294

Tumour necrosis factor-alpha production during cytomegalovirus infection in immunosuppressed rats.

B L Haagmans1, A J van den Eertwegh, E Claassen, M C Horzinek, V E Schijns.   

Abstract

The production of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1 and IL-6, all proinflammatory cytokines, was investigated in radiation-immunosuppressed rats infected with rat cytomegalovirus (RCMV). At day 7 post-infection, when the animals showed disease signs, high TNF-alpha levels were detected in the serum and in homogenates of various organ tissues. In contrast, IL-1 and IL-6 levels were not significantly elevated. Moreover, replication of RCMV induced TNF-alpha expression in different types of cells grown in vitro. When frozen tissue sections were examined by immunohistology, TNF-alpha-producing cells were found in areas with extensive pathology in the lungs, spleen and liver. Both lymphocytes and RCMV-infected cells were identified as the sources of TNF-alpha. Its abundance in RCMV-infected rats suggests an important role for TNF-alpha in CMV pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8151294     DOI: 10.1099/0022-1317-75-4-779

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection.

Authors:  S T Yerkovich; S D Olver; J C Lenzo; C D Peacock; P Price
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

2.  Role of trehalose dimycolate in recruitment of cells and modulation of production of cytokines and NO in tuberculosis.

Authors:  V M Lima; V L Bonato; K M Lima; S A Dos Santos; R R Dos Santos; E D Gonçalves; L H Faccioli; I T Brandão; J M Rodrigues-Junior; C L Silva
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

3.  Epileptogenesis due to glia-mediated synaptic scaling.

Authors:  Cristina Savin; Jochen Triesch; Michael Meyer-Hermann
Journal:  J R Soc Interface       Date:  2008-11-04       Impact factor: 4.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.